2018
DOI: 10.4162/nrp.2018.12.5.378
|View full text |Cite
|
Sign up to set email alerts
|

Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats

Abstract: BACKGROUND/OBJECTIVESBenign prostatic hypertrophy (BPH) is a major cause of abnormal overgrowth of the prostate mainly in the elderly. Corni Fructus has been reported to be effective in the prevention and treatment of various diseases because of its strong antioxidant effect, but its efficacy against BPH is not yet known. This study was designed to evaluate the therapeutic efficacy of Corni Fructus water extract (CF) in testosterone-induced BPH rats.MATERIALS/METHODSTo induce BPH, rats were intraperitoneal inj… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
17
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(19 citation statements)
references
References 42 publications
0
17
0
Order By: Relevance
“…61,62 This event results in the rise of PSA levels in prostate cancer patients as well as in the serum of BPH patients. 7 Therefore, alleviation in PSA levels may be a representative of the mitigation of BPH. We also studied how diosmin treatment against TP-induced hyperplasia could decrease the level of PSA.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…61,62 This event results in the rise of PSA levels in prostate cancer patients as well as in the serum of BPH patients. 7 Therefore, alleviation in PSA levels may be a representative of the mitigation of BPH. We also studied how diosmin treatment against TP-induced hyperplasia could decrease the level of PSA.…”
Section: Discussionmentioning
confidence: 99%
“…5 In addition, the serum level of the prostate-specific antigen (PSA) is elevated in BPH patients compared with unaffected men since PSA production is promoted by binding DHT to the androgen receptor (AR). 6,7 The important characteristics involved are gush in the smooth muscle tone and nonmalignant enlargement of the gland. 8 This may lead to recurrent urinary withholding, urinary tract infections, and erratic postrenal failure.…”
Section: Introductionmentioning
confidence: 99%
“…officinalis , called the SC extract. According to their pharmacological properties and a prior report [ 9 ] together with our previous study [ 10 ], a combination of these two plants may benefit from a synergistic effect and consequently promises to be an effective treatment for BPH.…”
Section: Introductionmentioning
confidence: 95%
“…In contrast, previous studies have shown that ursolic acid, oleanolic acid, and triterpenoids derived from C. officinalis , effectively suppressed the development of BPH in animal model [ 26 , 27 ]. In addition, the aqueous extract of C. officinalis inhibited testosterone-induced BPH, raising the intriguing concerns that the pharmacological functions of C. officinalis could not be described by only the major components [ 14 ]. Although many studies have implied the anti-BPH effect of C. officinalis and its compounds, neither the anti-proliferative effect of standardized C. officinalis on BPH nor the understanding of molecular mechanism could be considered in much detail.…”
Section: Discussionmentioning
confidence: 99%
“…These biological activities are consistent with those reported for the C. officinalis used as traditional medicine, which are TCM formulae to treat urinary frequency and seminal emission [ 13 ]. Furthermore, recent study has shown that aqueous extract of C. officinalis attenuates testosterone-induced benign prostatic hyperplasia (BPH) by suppressing androgen signaling pathway [ 14 ]. However, no study has investigated the exact molecular mechanism(s) underlying the anti-proliferative effects of standardized C. officinalis on prostatic cells.…”
Section: Introductionmentioning
confidence: 99%